Medizone International, Inc. (OTC:MZEI) share price jumped to $0.23 during yesterday’s trading session on twice the average trading volume. This was most probably initiated by the latest news in which the company announced a new distribution agreement, yet the traders’ reaction was rather modest. 
Wednesday trading session finished at $0.215 on a trading volume of 319,000 traded shares. The new closing price of MZEI is 2.87% higher than on Tuesday and the stock price looks now stable in this new trading range. MZEI jumped up from $0.12 in the middle of December last year.
Yesterday, MZEI said in a press release that it had signed a Letter of Understanding with a private Canadian company engaged in medical and veterinarian supply. Under the agreement, a newly created division of Canmedical would distribute AsepticSure in Canada. AsepticSure is a decontamination and infection control technology developed by Medizone International.
The technology should be presented right away and Canmedical had already committed to an initial order of four systems that would be delivered in the second quarter of the year.
Medizone International financials show that if the deal actually take place it would provide the company with its first sales. The market reaction yesterday did not suggest a lot of excitement, though, maybe because MZEI will need to raise new capital very soon if it is to cover its operations and pay out the accumulated liabilities.
